T he recent success of endovascular treatment (EVT) for acute ischemic stroke has changed clinical practice. According to a recent meta-analysis, the percentage of patients with good functional outcomes and early neurological recovery is higher when they undergo EVT compared with when they undergo control therapy. 1 However, EVT is associated with the innate risk of arterial wall injury because the therapeutic device inevitably contacts and scrapes the arterial walls during its retrieval. 2 Thus, we investigated postrecanalization arterial wall changes and their relationship with EVT technical factors, neurological outcomes, and hemorrhagic transformation using high-resolution vessel wall imaging (HR-VWI).
Methods
The subjects consisted of patients with acute stroke who were registered in the Korea University Stroke Registry-Guro Arm between January 2014 and December 2015. We selected subjects who met the following inclusion criteria: (1) acute ischemic stroke within 6 hours of the onset of symptoms, (2) treatment with acute recanalization therapy using intravenous tissue-type plasminogen activator infusion or EVT with successful recanalization and a Thrombolysis in Cerebral Infarct grade of 2b or 3, 3 (3) pretreatment occlusive lesion identified on the middle cerebral artery, distal internal carotid artery, or basilar artery, and (4) available HR-VWI scans ( Figure I in the online-only Data Supplement). We characterized the postrecanalization arterial wall changes as concentric enhancements or plaques. Concentric enhancements included concentric arterial wall thickenings with enhancement on contrast-enhanced T1-weighted imaging and none of the eccentric protrusions characteristic of arterial plaques (Figure 1 ). Concentric enhancements were usually found on long segments rather than on focal segments. Plaques were defined as eccentric focal arterial wall thickenings with variable enhancement on contrast-enhanced T1-weighted imaging. Cerebral arterial segments were classified as occlusive, proximal to occlusive, distal to occlusive, or contralateral to the occlusive segment. The thrombus extent (or occlusive segment) was defined as the segment from the proximal occlusive site to the end of the arterial segment. Plaques were defined as eccentric focal arterial wall thickenings with variable enhancement on contrast-enhanced T1-weighted imaging ( Figure 2) .
We examined the associations between postrecanalization changes and procedural factors, hemorrhagic transformation ( Figure I in the online-only Data Supplement), and neurological outcomes. The detailed acute stroke management protocol, magnetic resonance imaging protocol (Table I in the online-only Data Supplement), and the approval of the ethical review board are described in the Methods in the online-only Data Supplement.
Background and Purpose-Owing to the excellent recanalization rate of endovascular treatment, new outcome predictors are required for patients with acute stroke, who have sufficient recanalization. In this study, the effects of recanalization therapy on occluded arteries in patients with acute stroke were investigated using high-resolution vessel wall imaging. Methods-Twenty-nine patients with stroke were included in the study. High-resolution vessel wall imaging was performed on patients with acute stroke and adequate postrecanalization results. We characterized the postrecanalization arterial wall changes as concentric enhancements and plaques and examined the associations of the postrecanalization changes with procedural factors and neurological outcomes. Results-The most frequent high-resolution vessel wall imaging finding was concentric enhancement, which was associated with thrombectomy procedural factors such as the number of procedures and the type of device. Concentric enhancements were associated with hemorrhagic transformation, whereas plaque was not associated with procedural details. 
Conclusions-The

Results
In total, 29 patients with stroke (15 in the EVT group and 14 in the tissue-type plasminogen activator group) were included in the study (Table II in the online-only Data Supplement; Figure  II in the online-only Data Supplement). The mean interval between thrombolysis and HR-VWI was 3.66±1.52 days. Concentric enhancement was observed more frequently than plaques on HR-VWI (Table III in the online-only Data Supplement; Figure 1 ). The occurrence rate of concentric enhancements in the occlusive segment and proximal segments was significantly higher more frequent in the EVT group (10/15) than in the tissue-type plasminogen activator group (2/14). The occurrence rate of plaques was not significantly different between the EVT and tissue-type plasminogen activator groups.
The occurrence rate of concentric enhancements increased with increases in the thrombectomy trial number, retrievable stent trial number, and number of devices used (Table) . Patients with concentric enhancements had longer puncture to completion and puncture to first recanalization times (84.40±44.92 and 39.00±22.54 minutes, respectively) than those without concentric enhancements (59.80±30.74 and 28.00±13.93 minutes, respectively); however, these differences were not significant (P=0.310 and P=0.310, respectively). Concentric enhancements were found in 4 patients with plaques on occlusive segments and in 8 patients without plaques; however, these differences were not significant (P=0.668).
Hemorrhagic transformation was found in 10 patients (parenchymal hemorrhage type 1, n=3; hemorrhagic transformation type 2, n=2; and hemorrhagic transformation type 1, n=5). Concentric enhancements increased the risk for hemorrhagic transformation (58.3% in patients with concentric enhancement and 17.6% in patients without concentric enhancement; Fisher exact test; P=0.046; Table IV in the online-only Data Supplement). Considering the detailed degree of hemorrhagic transformation, concentric enhancement was associated with the degree of hemorrhagic transformation (Cochran-Armitage trend test; P=0.015; Figure  III in the online-only Data Supplement). An adjusted logistic regression model showed a significant association (odds ratio, 11.18; 95% confidence interval, 1.07-117.40; P=0.044) between concentric enhancements and hemorrhagic transformation. However, neurological outcomes measured using the modified Rankin Score at 3 months showed no association with the HR-VWI findings, including concentric enhancement (Table IV in the online-only Data Supplement).
Discussion
The main finding of this study is that procedure-related arterial wall changes were associated with hemorrhagic transformation. A causal relationship between the procedure and postrecanalization arterial wall changes could be analogized because concentric enhancements are associated with the number of thrombectomy trials or the number of devices used.
The devices used for mechanical thrombectomy cause various types of endothelial and medial wall injuries to vessels. 2 Retrievable stent devices inevitably make direct contact with arterial walls while capturing the clot. In addition, continuous radial force should be maintained against the vessel wall until the device enters the guiding catheter so that it does not miss the clot. In a swine model of acute stroke, the retrievable stent device led to more frequent spasms and distal embolization of the clot. 4 The resulting histological changes included endothelial denudation and formation of mural thrombi.
2 Accordingly, the concentric enhancements found in this study seem to correspond with endothelial damage or spasms. Considering that disruptions of the endothelial lining of the blood-brain barrier are associated with hemorrhagic transformation, 5 concentric enhancements seem to be plausible markers for intracranial hemorrhage.
Traditionally, a concern exists when EVT is performed for the patients with intracranial atherosclerosis because EVT has the potential to injure arterial walls, causing vasospasm, dissection, inadvertent detachment, or distal embolization of the clot, if there is an intracranial atherosclerotic plaque on the occlusive segment. 6 In our patient series, contrary to our expectations, the association between plaques and procedural details was obscure. However, a cautious interpretation of this result is warranted because of the study's narrow inclusion criteria for successful recanalization and the small sample size of the study.
Despite its several limitations, such as small sample size, ethnic limitations, a treatment-to-image time lag, and a lack of pathological data, our study validated the impact of postrecanalization arterial wall changes on clinical outcomes, thereby highlighting the clinical relevance of our findings. In addition, HR-VWI after recanalization seems to be a feasible and useful technique for the understanding of postrecanalization vascular status. 
